Bipolar Disorder.
Ann Intern Med
; 175(7): ITC97-ITC112, 2022 07.
Article
en En
| MEDLINE
| ID: mdl-35816713
ABSTRACT
Bipolar disorder (BD) affects approximately 2% of U.S. adults and is the most costly mental health condition for commercial insurers nationwide. Rates of BD are elevated among persons with depression, anxiety disorders, and substance use disorders-conditions frequently seen by primary care clinicians. In addition, antidepressants can precipitate manic or hypomanic symptoms or rapid cycling in persons with undiagnosed BD. Thus, screening in these high-risk groups is indicated. Effective treatments exist, and many can be safely and effectively administered by primary care clinicians.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Trastorno Bipolar
Tipo de estudio:
Diagnostic_studies
Idioma:
En
Revista:
Ann Intern Med
Año:
2022
Tipo del documento:
Article